| (P186) |
Endothelium-depent prothrombotic and fibrinolytic factors in patients with ischemic heart disease and chronic heart failure. |
|
E.V. Shlyakhto, K.A. Khmelnitskaya, M.U. Sitnikova (Saint Petersburg, RU) |
| (P187) |
C-Reactive protein and complement C3: associations with haemostatic and cardiovascular risk factors in the Leeds Family Study. |
|
U.K. Prasad, A.M. Carter, M.S. Freeman, P.J. Grant (Leeds, GB) |
| (P188) |
The use of plasma NT-pro BNP, Interleukin 6, TNFα and sCD 40L in assessment of acute heart failure severity in emergency department. |
|
R. Pudil, C. Andrys, M. Tichy, J. Vojacek (Hradec Kralove, CZ) |
| (P189) |
High-sensitivity C-reactive protein predicts the presence of coronary artery disease in non-selected, consecutive patients undergoing coronary angiograpy. |
|
H.F. Alber, A. Suessenbacher, J. Doerler, A. Ladurner, J.R. Kurz, W. Dichtl, M. Frick, O. Pachinger, F. Weidinger (Innsbruck, AT) |
| (P190) |
Circulating tissue kallikrein is upregulated in patients with acute myocardial infarction and correlates with functional, biochemical and cellular markers of adverse clinical outcome. |
|
W. Wojakowski, R. Wyderka, M. Tendera, A. Zebzda, M. Majka, M. Ratajczak, C. Emanueli, P. Madeddu (Katowice and Kraków, PL; Louisville, US; Bristol, GB) |
| (P191) |
Change of compliance of the allogenic vascular grafts implanted in infected environment. |
|
M. Gabriel, K. Wachal, K. Pawlaczyk, G. Oszkinis, A. Korcz (Poznań, PL) |
| (P192) |
Markers of inflammation and vascular disease. |
|
E. Dósa, A. Szabó, S. Rugonfalvi-Kiss, L. Selmeci, G. Füst, L. Entz (Budapest, HU) |
| (P193) |
Inflammatory markers and restenosis after coronary stenting. Effects of statins. |
|
I. Raimbekova, M. Ezhov, A. Sumarokov, A. Samko, V. Masenko, V. Naumov (Moscow, RU) |
| (P194) |
C-reactive protein and complement in angiotensin II-induced organ damage. |
|
E. Shagdarsuren, M. Wellner, J-H. Braesen, J-K. Park, N. Henke, R. Dechend, P. Gratze, A. Fiebeler, F.C. Luft, D.N. Mueller (Berlin and Hannover, DE) |
| (P195) |
Autoantibody titers against various forms of modified LDL in patients with stable angina are influenced by the lipoprotein-associated phospholipase A2 (PAF-acetylhydrolase) activity and the extent of oxidation. |
|
A. Papathanasiou, E. Lourida, J. Goudevenos, A. Tselepis (Ioannina, GR) |
| (P196) |
Associations of C-reactive protein and complement C3 levels in patients with myocardial infarction. |
|
U.K. Prasad, P.J. Grant, A.M. Carter (Leeds, GB) |
| (P197) |
Endothelial proliferation, migration and transformation during the initial phases of intimal formation. |
|
M.C. DeRuiter, P.H.A. Quax, C.J. VanMunsteren, N. Aoyama, B.P. Hierck, A.C. Gittenberger-de Groot (Leiden, NL; Kanagana, JP) |
| (P198) |
S100A4: a marker for activated smooth muscle cells in atherosclerosis and restenosis. |
|
A.C. Brisset, M. Bacchetta, A. Geinoz, Chr. Chaponnier, H. Hao, J-C. Sanchez, E. Camenzind, G. Gabbiani, M-L. Bochaton-Piallat, for Department of Pathology and Immunology - Faculty of Medicine Geneva - CMU (Geneva, CH; Hyogo, JP) |